Marketing Professionals Say AI Influencers are Here to Stay

 

Let’s talk about AI influencers. You may have heard about Miquela Sousa, the 19-year-old Brazilian-American model and definitely not a real human getting ‘hacked’ in 2018 by a pro-Trump Influencer. No? What about Maybelline unveiling ‘May’, its own digital influencer created to sell mascara? Like it or not, AI influencers, or more concretely, animated and curated virtual avatars used to market products or build relationships with consumer communities have gone mainstream and signs point to them being here to stay. But where did they come from?

An interesting parallel that sheds light on why AI influencers seem to work with consumers is virtual bands. Long before we had influencers, there were “fake” bands that still really wanted to sell you things. Many cite Alvin and the Chipmunks as the first virtual band, but more recent and popular examples include the Gorillaz and Hatsune Miku. All of these examples, like AI influencers, were intentionally built to create a brand, sell a product, and build community with eager consumers and fans, and all of them have millions of adoring fans. There’s a certain allure that a digital-native age has with virtual curated personalities, even if it’s clear that they’re inauthentic avatars.

As to where AI influencers are headed, Anna Sullivan, Founder and CEO of creative digital marketing company The Creative Exchange, thinks that not only are AI influencers here to stay, but we “haven’t seen nothing” yet.

Anna’s Thoughts

“Over the past few years, you may have seen AI influencers as well as digital avatars on social media such as Miquela. Recently, Maybelline used a digital avatar to launch their latest product campaign. This is not something that is going to go away anytime soon. This is just scratching the surface. It’s gonna be the future, especially as every brand gets into the metaverse.

This type of technology won’t be replacing influencer marketing or UGC creators as people still look for real people to trust and connect with for their product reviews, but this is gonna be a new type of technology that all brands will be using at least in the next five years.”

Article written by Graham P. Johnson.

Follow us on social media for the latest updates in B2B!

Image

Latest

Doable
Rethinking Leadership: Why “Doable” Might Be the Most Powerful Strategy in Education Today
April 3, 2026

At a time when educator burnout is rising and schools across the U.S. are facing ongoing teacher shortages, leaders are being forced to rethink what sustainable success actually looks like. Research shows that teacher attrition is closely tied to working conditions, job-related stress, and workload demands. As districts push for innovation, data-driven instruction, and…

Read More
Casey Brown
From Poverty to Pricing Power | Why Great Companies Undercharge
April 2, 2026

Casey Brown didn’t grow up thinking she would become an entrepreneur. She grew up in a blue-collar family where money was always tight — close enough to the edge that the fear of poverty shaped many of her early decisions. That fear led her into engineering, into corporate America, and eventually into a moment…

Read More
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
April 2, 2026

In this episode of Care Anywhere, host Lea Sims sits down with Nigerian nurse entrepreneur and advocate Obafemi Arowosegbe to discuss leadership, mentorship, and the future of nursing in Africa. While still a nursing student, Obafemi founded the Nightingale Summit, a growing conference designed to empower nursing students and early-career nurses with leadership skills,…

Read More
Oncology
From Denial to Access: Rethinking Oncology Care Through AI, Clinical Trials, and Patient-Centered Innovation
April 1, 2026

The rapid expansion of precision medicine, biologics, and targeted cancer therapies is transforming oncology—but it’s also overwhelming a system not built to keep pace. In the U.S., cancer drugs now account for some of the highest-cost treatments in healthcare, and with that has come a surge in prior authorization requirements and denials. Studies suggest physicians…

Read More